Sameep Sehgal

ORCID: 0000-0003-4413-1902
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • COVID-19 Clinical Research Studies
  • Polyomavirus and related diseases
  • Sarcoidosis and Beryllium Toxicity Research
  • Organ and Tissue Transplantation Research
  • Mechanical Circulatory Support Devices
  • Long-Term Effects of COVID-19
  • Tracheal and airway disorders
  • Pulmonary Hypertension Research and Treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Intensive Care Unit Cognitive Disorders
  • Eosinophilic Disorders and Syndromes
  • Medical Imaging and Pathology Studies
  • Respiratory viral infections research
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Impact on Reproduction
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Respiratory and Cough-Related Research
  • Fungal Infections and Studies
  • Asthma and respiratory diseases

Cleveland Clinic
2015-2024

Lady Hardinge Medical College
2024

Temple University Hospital
2020-2022

Temple University
2018-2021

Philadelphia University
2021

Temple University Health System
2020

Sir Ganga Ram Hospital
2005

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant reductions in transplantation, motivated part by concerns of disproportionately more severe among solid organ transplant (SOT) recipients. However, clinical features, outcomes, and predictors mortality SOT recipients are not well described. Methods We performed a multicenter cohort study with laboratory-confirmed COVID-19. Data were collected using standardized intake 28-day follow-up electronic case...

10.1093/cid/ciaa1097 article EN other-oa Clinical Infectious Diseases 2020-08-04
Roberto Caricchio Antonio Abbate И. Г. Гордеев Jamie Meng Priscilla Y. Hsue and 95 more Tuhina Neogi Roberto C. Arduino Daria Fomina Roman Bogdanov T. Stepanenko Pilar Ruíz-Seco Andrés González García Yu Chen Yuhan Li Sarah Whelan Stephanie Noviello Stanislas Faguer Alberto Papi Fabiano Di Marco Alina S. Agafina Anastasia Mochalova Dmitry Lioznov Dmitry V. Privalov Konstantin Vasilievich Trufanov Tatiana Martynenko José Luis Pablos-Alvarez Segundo Buján Vicente Estrada Xavier Solanich Harpal S. Randeva Hasan Tahir Helen J. Lachmann Sinisa Savic Vishal Patel Anne M. Lachiewicz Babafemi Taiwo Daniel R. Kuritzkes Jeffrey M. Jacobson Joel V. Chua Mihran Shirinian Monica Fung Edgar T. Overton Vinay Malhotra Eugene Y. Kissin Natalia E. Morone Manish Sagar Marcin A. Trojanowski Parag Desai Samuel L. Krachman Daniel Salerno Jeffrey Stewart Matthew Zheng Rohit Gupta Kartik Shenoy Nathaniel Marchetti M. Patel Fredric Jaffe J.M. Chowdhury James C. Brown Maria Elena Vega‐Sanchez Stephen Codella S. Verga Gustavo Fernandez-Romero Janpreet Mokha Gerard J. Criner Parth Rali Sameep Sehgal Z. Dorey-Stein Aditi Satti Eduardo Dominguez-Castillo Nicole Mills A.J. Mamary A.J. Gangemi Jacob Shani Robert Frankel Kavita Sharma Yury Malyshev Jason Brady Manan Christian Gwendolyn Tan-Augenstein Damian A. Chiandussi Ann Behne Mellisa Black Aldo Bonaventura Rick Earl Clary Henley Deutsch Christina Duke Joan Greer Mary Hardin Mary Harmon Heather Kemp Ai‐Chen Ho Ikenna Ibe Amy C. Ladd Amr Marawan Roshanak Markley Kim McKee Virginia Mihalick Alison Montpetit James Mbualungu

Effective treatments for patients with severe COVID-19 are needed.To evaluate the efficacy of canakinumab, an anti-interleukin-1β antibody, in hospitalized COVID-19.This randomized, double-blind, placebo-controlled phase 3 trial was conducted at 39 hospitals Europe and United States. A total 454 pneumonia, hypoxia (not requiring invasive mechanical ventilation [IMV]), systemic hyperinflammation defined by increased blood concentrations C-reactive protein or ferritin were enrolled between...

10.1001/jama.2021.9508 article EN JAMA 2021-07-20

Solid organ transplant recipients are considered at high risk for COVID-19 infection due to chronic immune suppression; little data currently exists on the manifestations and outcomes of in lung recipients. Here we report 8 cases identified patients with a history transplant. We describe clinical course disease as well preexisting characteristics these patients.

10.1111/tid.13364 article EN Transplant Infectious Disease 2020-06-10
Madeleine R. Heldman Olivia S. Kates Kassem Safa Camille N. Kotton Ashrit Multani and 95 more Sarah J. Georgia Julie M. Steinbrink Barbara D. Alexander Emily A. Blumberg Brandy Haydel Vagish Hemmige Marion Hemmersbach‐Miller Ricardo M. La Hoz Lisset Moni Yesabeli Condor Sandra Flores C. Muñoz Juan Guitierrez Esther I. Diaz Daniela Diaz Rodrigo Vianna Giselle Guerra Matthias Loebe Julie M. Yabu Kailey Hughes Kramer Sajal D. Tanna Michael G. Ison Robert M. Rakita Maricar Malinis Marwan M. Azar Margaret McCort Pooja Singh Arzu Velioğlu Sameer Mehta David van Duin Jason D. Goldman Erika D. Lease Anna Wald Ajit P. Limaye Cynthia E. Fisher Behdad Besharatian M. Crespo Rade Tomic Sameep Sehgal Dana Weisshaar Reda E. Girgis Christine Lawrence Joanna Nelson William M. Bennett J. C. LEANDRO Afrah S. Sait A. Rumore Peter West Amy Jeng Valida Bajrovic Erin P Bilgili Tracy Anderson-Haag A Năstase Abbas Badami Jesús Álvarez‐García Lyndsey Bowman-Anger L. Julien Carlos Ortiz‐Bautista Rachel Friedman-Morocco Kiran Gajurel Lizbeth Cahuayme‐Zuniga Mark R. Wakefield Monica Fung Nicole Theodoropoulos Sally T Chuang Srividya Bhandaram Massimiliano Veroux Bhavna Chopra Diana F. Florescu Danielle Witteck Daniela Díaz Kathryn Ripley Kapil Saharia Sanjeev Akkina Todd P McCarty A.K. Webb Akanksha Arya Giridhar Vedula J.M. El-Amm M. Katherine Dokus Arun Narayanan Priscila Cilene León Bueno de Camargo Rosemary Ouseph Andrew Breuckner Alfred Luk Avinash Aujayeb Daniel Ganger Douglas S. Keith Federica Meloni Ghady Haidar Lori Zapernick Megan Morales Nitender Goyal Tanvi Sharma Uma Malhotra

Most studies of solid organ transplant (SOT) recipients with COVID-19 focus on outcomes within one month illness onset. Delayed mortality in SOT hospitalized for has not been fully examined.

10.1093/cid/ciac159 article EN Clinical Infectious Diseases 2022-02-23

The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg (sarcoidosis A) are grouped COPD >30 D) idiopathic fibrosis (IPF). We hypothesise that have a higher than other within their LAS grouping.This is retrospective cohort study of consecutive from the Scientific Registry Transplant Recipients database May 2005 to...

10.1183/23120541.00738-2022 article EN cc-by-nc ERJ Open Research 2023-06-01

A 58-year-old woman with stage 4 adenocarcinoma of the lung being treated pembrolizumab developed dyspnea, non-productive cough, and a right middle lobe infiltrate. Complete resolution infiltrate cessation pembrolizumab, initiation prednisone no antibiotic therapy suggested drug-associated toxicity as cause. While programmed death-1 (PD-1) inhibitors –pembrolizumab nivolumab – have been implicated cause diffuse or multifocal pulmonary infiltrates, current case represents, to our knowledge,...

10.1016/j.rmcr.2016.09.001 article EN cc-by-nc-nd Respiratory Medicine Case Reports 2016-01-01

Purpose of Review To review what is currently known about the pathogenesis, diagnosis, treatment, and prevention acute rejection (AR) in lung transplantation. Recent Findings Epigenomic transcriptomic methods are gaining traction as tools for earlier detection AR, which still remains primarily a histopathologic diagnosis. Summary Acute common cause early posttransplant graft dysfunction increases risk chronic rejection. Detection diagnosis AR based on histopathology, but noninvasive...

10.1097/mcp.0000000000001078 article EN Current Opinion in Pulmonary Medicine 2024-04-24

Physical health status defines an individual's ability to perform normal activities of daily living and is usually assessed in clinical settings by questionnaires and/or validated tests, e.g. timed walk tests. These measurements have relatively low information content are limited frequency. Wearable sensors, such as activity monitors, enable remote measurement parameters associated with physical but not been widely explored beyond step count. Here we report on results from a cohort 22...

10.1038/s41746-022-00696-5 article EN cc-by npj Digital Medicine 2022-11-09
Coming Soon ...